Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases

被引:22
|
作者
Shoji, Jun [1 ]
机构
[1] Nihon Univ, Dept Visual Sci, Div Ophthalmol, Sch Med,Itabashi Ku, 30-1 Ohyaguchi Kamicho, Tokyo 1738610, Japan
关键词
Eosinophil cationic protein; Eotaxin-2; Histamine H-4 receptor; Ocular allergy test; Th2; chemokine; EOSINOPHIL CATIONIC PROTEIN; ATOPIC KERATOCONJUNCTIVITIS; VERNAL KERATOCONJUNCTIVITIS; H4; RECEPTORS; H-4; RECEPTOR; TEAR LEVELS; EOTAXIN; EXPRESSION; PERIOSTIN; INFLAMMATION;
D O I
10.1016/j.alit.2020.05.003
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Allergic conjunctival diseases (ACDs) are inflammatory diseases of the conjunctiva and cornea caused predominantly by the IgE-mediated immediate hypersensitivity response. Allergic conjunctival diseases include allergic conjunctivitis, vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC), and giant papillary conjunctivitis. In clinical practice of ACDs, an ocular allergy test using biomarker measurement is a crucial examination technique for diagnosing, evaluating severity, and determining the efficacy of medical treatment. The ocular allergy test includes the tear test for evaluating the concentration of biomarkers in tears and an ocular surface test for assessing the expression levels of messenger ribonucleic acid (mRNA) biomarkers on the ocular surface. The clinical usefulness of several biomarkers has been demonstrated in patients with ACDs; specifically, eosinophil cationic protein and eotaxin-2 as eosinophilic inflammation biomarkers; interleukin-4 and thymus and activation regulated chemokine (CCL17/TARC) as Th2 inflammation biomarkers; eotaxin, tumor necrosis factor-alpha and soluble IL-6 receptor as giant papillae biomarkers; and osteopontin and periostin as allergic inflammation and remodeling biomarkers. Furthermore, the ocular allergy test, quantitative evaluation methods using biomarkers have allowed for better understanding of the immunological and pathophysiological mechanisms of ACDs. Therefore, the search for a biomarker is important to make an ocular allergy test useful. In previous ocular allergy tests, the biomarkers for allergic inflammation in patients with chronic ACDs including VKC and AKC were substantial. However, the selection of biomarkers associated with the early phase reaction of immediate hypersensitivity and innate immunity responses needs to be addressed in future investigations. Copyright (C) 2020, Japanese Society of Allergology. Production and hosting by Elsevier B.V.
引用
收藏
页码:496 / 504
页数:9
相关论文
共 50 条
  • [41] The use of tear ferning test in cats for evaluation of ocular surface
    Jéssica Fontes Veloso
    Arianne Pontes Oriá
    Ana Cláudia Santos Raposo
    Ariane Jesus Lacerda
    Cláudia Vital Borges Silva
    Larissa Ferreira Lima
    Renata Santiago Alberto Carlos
    Acta Veterinaria Scandinavica, 62
  • [42] ALLOGRAFT CONJUNCTIVAL TRANSPLANTATION FOR BILATERAL OCULAR SURFACE DISORDERS
    KWITKO, S
    MARINHO, D
    BARCARO, S
    BOCACCIO, F
    RYMER, S
    FERNANDES, S
    NEUMANN, J
    OPHTHALMOLOGY, 1995, 102 (07) : 1020 - 1025
  • [43] Conjunctival Impression Cytology for the Evalution of Ocular Surface Changes
    Haller-Schober, E-M
    Horwath-Winter, J.
    Boldin, I
    Rabensteiner, D. F.
    Fischl, M.
    Chr, Faschinger
    INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS (ISOPT), 2012, : 11 - 17
  • [44] Conjunctival epithelial keratin expression in ocular surface disease
    Ye, HQ
    Chan, CC
    Whitcup, SM
    Smith, JA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S457 - S457
  • [45] Photodynamic Therapy for Conjunctival Ocular Surface Squamous Neoplasia
    Cekic, Osman
    Bardak, Yavuz
    Kapucuoglu, Nilgun
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (02) : 205 - 207
  • [46] CONJUNCTIVAL GOBLET CELL DENSITIES IN OCULAR SURFACE DISEASE
    NELSON, JD
    WRIGHT, JC
    ARCHIVES OF OPHTHALMOLOGY, 1984, 102 (07) : 1049 - 1051
  • [47] Conjunctival scar excision in severe ocular surface disease
    Wilker, SC
    Bardenstein, DS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [48] Conjunctival organoids as a replacement therapy for ocular surface defects
    Dickman, M. M.
    Schaafsma, M.
    Bannier-Helaouet, M.
    Clevers, H.
    LaPointe, V.
    ACTA OPHTHALMOLOGICA, 2023, 101 : 10 - 10
  • [49] Ocular surface fibroma as a differential diagnosis in conjunctival lesions
    Frauches, R.
    Bishay, M.
    Lin, J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (06): : 492 - 492
  • [50] Role of the ocular surface microbiome in allergic disease
    Cavuoto, Kara M.
    Stradiotto, Allison C.
    Galor, Anat
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (05) : 482 - 487